GlassScriptPhysician profile
Mohammad J Tariq
NPI 1639171887
$600.37
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $70.89 · 2021: $86.37 · 2022: $188 · 2023: $38.31 · 2024: $77.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $62.29 · Travel and Lodging: $53.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $62.29 |
| Travel and Lodging | $53.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $231.55 | 2019-2022 | |
| Spinal Simplicity, LLC | $77.83 | 2024 | Ha Minuteman G3-R |
| Medtronic, INC. | $68.16 | 2021-2022 | |
| Nevro Corp. | $42.01 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $25.96 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $23.09 | 2021 | |
| Depuy Synthes Sales INC. | $20.60 | 2023 | Teligen |
| Novartis Pharmaceuticals Corporation | $18.99 | 2019 | |
| Amgen INC. | $18.76 | 2019 | |
| Forte Bio-Pharma LLC | $17.71 | 2023 | Prolate, Nalocet |
| Boston Scientific Corporation | $16.11 | 2019 | |
| Pfizer INC. | $14.47 | 2020 | |
| Biodelivery Sciences International, INC. | $12.85 | 2019 | |
| Vertiflex, INC. | $12.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Tariq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.